doi:10.14260/jemds/2015/2404Amin RahemtullaEvangelos TerposBMJ Clin EvidBmj Clinical EvidenceRahemtulla A, Terpos E. Hodgkin's lymphoma (relapsed or refractory): autologous stem cell therapy. BMJ Clin Evid 2015;2015.
CAR T细胞疗法最初是针对某些类型的血液肿瘤,特别是急性淋巴细胞性白血病(Acute Lymphoblastic Leukemia, ALL)和非霍奇金淋巴瘤(Non-Hodgkin Lymphoma, NHL)。这种疗法在一些临床试验中显示出非常有希望的结果。例如,在对于难治性或复发性ALL的儿童和成...
M.S., Einsele, H., Noppeney, R., Hess, G., Kallert, S., Mackensen, A., et al. (2016). Bispecific T-cell engager (BiTE) antibody construct Blinatumomab for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma: final results from a Phase I study. J. Clin. Oncol...
Hodgkin's Lymphoma-like Posttransplantation Lymphoproliferative Disorder after Allogeneic Hematopoietic Stem Cell Transplantation 喜欢 0 阅读量: 8 作者: DOI Medicine,BP Hospital,Inje University College of Medicine,Busan,Korea.,Inje University College of 关键词: Hematology DOI: 10.5045/kjh.2009.44....
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin′s lymphoma: results of outpatient treatment in community cancer centers. Weaver CH,Schwartzcerg L,Zhen B et al. Bone Marrow Transplantation . 1997
several investigations have demonstrated that KIR haplotypes predict the prognosis and the conversion of MDS to AML47; the incidence of leukemia48and solid tumors49; the prognosis of classical Hodgkin’s lymphoma50; the prognosis and response to targeted therapies in colorectal cancer51,52; and the...
doi:10.1080/10245332.2000.11746492BrunoGabrielaV.BallesterOscarF.Hematology
For patients with relapsed Hodgkin's lymphoma (HL), high dose chemotherapy with stem cell rescue (HDCT-SCT) may improve survival over chemotherapy alone. We assessed the outcomes of HDCT-SCT in 37 consecutive adolescent and young adult patients with relapsed HL whose malignancy was categorized ba...
Spontaneous regression of a small non‐cleaved cell malignant lymphoma (Non‐burkitt's lymphoblastic lymphoma). Morphologic, immunohistological, and immuno... Complete spontaneous regression of high-grade malignant non-Hodgkin's lymphoma is extremely unusual. In this report the authors describe a ...
toward a new therapeutic target STEM CELLS IN HODGKIN LYMPHOMAKim, Seok Jin